Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms - Drugs.com MedNews
Links shared publicly online about this topic.
- 0total visits
Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms - Drugs.com MedNews
AUDIENCE Oncology, Anesthesiology ISSUE FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea
View full resource at drugs.com
Tags: Heart, Nausea and Vomiting Medication, Drug, Zofran, Oncology, Anesthesiology, Safety
Most Recently Shared on September 16, 2011 at 2:06 pm By:
Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms: AUDIENCE: Oncology, Anes... http://t.co/lIQf0lLi #drug
Advertisement
